Yi Xia
机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0009-0003-1526-1043
发表论文 19 篇
代表论文
- Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications (2026 · Nature Communications)
- Supplementary Table S8 from LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial (2026)
- Supplementary Figure S1 from LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial (2026)
- Supplementary Table S6 from LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial (2026)
- Supplementary Table S7 from LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial (2026)
- Supplementary Figure S4 from LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial (2026)